[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 5059 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  2d Session
                                S. 5059

  To amend the Public Health Service Act to streamline the review of 
                    biosimilar biological products.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 21, 2026

Mrs. Moody (for herself, Ms. Alsobrooks, Mr. Scott of Florida, and Ms. 
 Blunt Rochester) introduced the following bill; which was read twice 
and referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
  To amend the Public Health Service Act to streamline the review of 
                    biosimilar biological products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. STREAMLINING BIOSIMILAR REVIEWS.

    Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 
262(k)(5)) is amended--
            (1) by striking subparagraph (B); and
            (2) by redesignating subparagraph (C) as subparagraph (B).
                                 <all>